 |
Tyloxapol |
|---|---|
| Trade Name | Supervent |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1995-03-08 00:00:00 |
| Sponsor | Kennedy & Hoidal, M.D.'s;University of Utah Health Sciences Center, 50 North Medical Drive, Room 4R240;Salt Lake City, Utah, 84132 |
Related Access Program